Annual SG&A
$12.69 M
-$12.00 K-0.09%
31 December 2023
Summary:
Eledon Pharmaceuticals annual selling, general & administrative expenses is currently $12.69 million, with the most recent change of -$12.00 thousand (-0.09%) on 31 December 2023. During the last 3 years, it has fallen by -$444.00 thousand (-3.38%). ELDN annual SG&A is now -3.38% below its all-time high of $13.13 million, reached on 31 December 2021.ELDN Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$3.99 M
-$406.00 K-9.24%
30 September 2024
Summary:
Eledon Pharmaceuticals quarterly selling, general & administrative expenses is currently $3.99 million, with the most recent change of -$406.00 thousand (-9.24%) on 30 September 2024. Over the past year, it has increased by +$719.00 thousand (+21.98%). ELDN quarterly SG&A is now -34.94% below its all-time high of $6.13 million, reached on 30 June 2017.ELDN Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$1.27 B
-$77.40 M-6.48%
30 September 2024
Summary:
Eledon Pharmaceuticals TTM selling, general & administrative expenses is currently -$1.27 billion, with the most recent change of -$77.40 million (-6.48%) on 30 September 2024. Over the past year, it has dropped by -$1.28 billion (-10123.62%). ELDN TTM SG&A is now -1916.96% below its all-time high of $15.12 million, reached on 30 September 2024.ELDN TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ELDN Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +22.0% | -10000.0% |
| 3 y3 years | -3.4% | +24.6% | -9784.7% |
| 5 y5 years | +109.5% | +312.6% | -10000.0% |
ELDN Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -3.4% | at low | -9.2% | +43.0% | -213.1% | at low |
| 5 y | 5 years | -3.4% | +109.5% | -9.2% | +312.6% | -511.4% | at low |
| alltime | all time | -3.4% | +555.0% | -34.9% | +1073.5% | -1917.0% | at low |
Eledon Pharmaceuticals Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $3.99 M(-9.2%) | $15.12 M(+5.0%) |
| June 2024 | - | $4.40 M(+27.1%) | $14.39 M(+9.5%) |
| Mar 2024 | - | $3.46 M(+5.7%) | $13.15 M(+3.6%) |
| Dec 2023 | $12.69 M(-0.1%) | $3.27 M(+0.1%) | $12.69 M(+3.9%) |
| Sept 2023 | - | $3.27 M(+3.6%) | $12.21 M(+1.0%) |
| June 2023 | - | $3.15 M(+5.2%) | $12.09 M(-3.1%) |
| Mar 2023 | - | $3.00 M(+7.4%) | $12.47 M(-1.8%) |
| Dec 2022 | $12.70 M(-3.3%) | $2.79 M(-11.3%) | $12.70 M(-3.1%) |
| Sept 2022 | - | $3.15 M(-11.1%) | $13.11 M(+2.3%) |
| June 2022 | - | $3.54 M(+9.8%) | $12.81 M(-1.5%) |
| Mar 2022 | - | $3.22 M(+0.7%) | $13.00 M(-1.0%) |
| Dec 2021 | $13.13 M(+30.6%) | $3.20 M(+12.5%) | $13.13 M(-0.9%) |
| Sept 2021 | - | $2.85 M(-23.6%) | $13.25 M(-6.2%) |
| June 2021 | - | $3.73 M(+11.2%) | $14.13 M(+21.1%) |
| Mar 2021 | - | $3.35 M(+0.9%) | $11.67 M(+16.1%) |
| Dec 2020 | $10.05 M(+66.0%) | $3.32 M(-11.0%) | $10.05 M(+30.6%) |
| Sept 2020 | - | $3.73 M(+194.0%) | $7.70 M(+43.1%) |
| June 2020 | - | $1.27 M(-26.6%) | $5.38 M(-8.9%) |
| Mar 2020 | - | $1.73 M(+78.9%) | $5.90 M(-2.6%) |
| Dec 2019 | $6.06 M(-16.4%) | $967.00 K(-31.5%) | $6.06 M(-12.6%) |
| Sept 2019 | - | $1.41 M(-21.3%) | $6.93 M(-5.9%) |
| June 2019 | - | $1.79 M(-5.0%) | $7.36 M(-0.9%) |
| Mar 2019 | - | $1.89 M(+2.7%) | $7.43 M(+2.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | $7.24 M(-34.7%) | $1.84 M(-0.6%) | $7.24 M(+3.2%) |
| Sept 2018 | - | $1.85 M(-0.6%) | $7.02 M(-7.9%) |
| June 2018 | - | $1.86 M(+9.5%) | $7.62 M(-35.9%) |
| Mar 2018 | - | $1.70 M(+5.3%) | $11.89 M(+7.1%) |
| Dec 2017 | $11.10 M(+473.0%) | $1.61 M(-34.2%) | $11.10 M(+9.9%) |
| Sept 2017 | - | $2.45 M(-60.1%) | $10.10 M(+22.9%) |
| June 2017 | - | $6.13 M(+576.9%) | $8.21 M(+239.3%) |
| Mar 2017 | - | $906.00 K(+48.3%) | $2.42 M(-52.2%) |
| Dec 2016 | $1.94 M(-84.7%) | $611.00 K(+8.3%) | $5.06 M(-35.0%) |
| Sept 2016 | - | $564.00 K(+65.9%) | $7.79 M(-26.8%) |
| June 2016 | - | $340.00 K(-90.4%) | $10.64 M(-20.8%) |
| Mar 2016 | - | $3.55 M(+6.3%) | $13.43 M(+6.4%) |
| Dec 2015 | $12.62 M(+42.1%) | $3.34 M(-2.3%) | $12.62 M(+7.5%) |
| Sept 2015 | - | $3.42 M(+9.2%) | $11.74 M(-1.5%) |
| June 2015 | - | $3.13 M(+14.1%) | $11.92 M(+15.9%) |
| Mar 2015 | - | $2.74 M(+11.6%) | $10.29 M(+15.8%) |
| Dec 2014 | $8.88 M(+150.4%) | $2.46 M(-31.7%) | $8.88 M(+16.5%) |
| Sept 2014 | - | $3.60 M(+141.1%) | $7.63 M(+62.6%) |
| June 2014 | - | $1.49 M(+11.8%) | $4.69 M(+46.7%) |
| Mar 2014 | - | $1.34 M(+11.3%) | $3.20 M(+71.8%) |
| Dec 2013 | $3.55 M(+55.7%) | $1.20 M(+81.5%) | $1.86 M(+181.5%) |
| Sept 2013 | - | $661.00 K | $661.00 K |
| Dec 2012 | $2.28 M | - | - |
FAQ
- What is Eledon Pharmaceuticals annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Eledon Pharmaceuticals?
- What is Eledon Pharmaceuticals quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Eledon Pharmaceuticals?
- What is Eledon Pharmaceuticals quarterly SG&A year-on-year change?
- What is Eledon Pharmaceuticals TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Eledon Pharmaceuticals?
- What is Eledon Pharmaceuticals TTM SG&A year-on-year change?
What is Eledon Pharmaceuticals annual selling, general & administrative expenses?
The current annual SG&A of ELDN is $12.69 M
What is the all time high annual SG&A for Eledon Pharmaceuticals?
Eledon Pharmaceuticals all-time high annual selling, general & administrative expenses is $13.13 M
What is Eledon Pharmaceuticals quarterly selling, general & administrative expenses?
The current quarterly SG&A of ELDN is $3.99 M
What is the all time high quarterly SG&A for Eledon Pharmaceuticals?
Eledon Pharmaceuticals all-time high quarterly selling, general & administrative expenses is $6.13 M
What is Eledon Pharmaceuticals quarterly SG&A year-on-year change?
Over the past year, ELDN quarterly selling, general & administrative expenses has changed by +$719.00 K (+21.98%)
What is Eledon Pharmaceuticals TTM selling, general & administrative expenses?
The current TTM SG&A of ELDN is -$1.27 B
What is the all time high TTM SG&A for Eledon Pharmaceuticals?
Eledon Pharmaceuticals all-time high TTM selling, general & administrative expenses is $15.12 M
What is Eledon Pharmaceuticals TTM SG&A year-on-year change?
Over the past year, ELDN TTM selling, general & administrative expenses has changed by -$1.28 B (-10123.62%)